Kim, Jiyeon http://orcid.org/0000-0002-0138-1920
Lee, Hyun Min
Cai, Feng
Ko, Bookyung
Yang, Chendong
Lieu, Elizabeth L.
Muhammad, Nefertiti
Rhyne, Shawn
Li, Kailong http://orcid.org/0000-0002-3311-5782
Haloul, Mohamed
Gu, Wen http://orcid.org/0000-0002-3003-8945
Faubert, Brandon http://orcid.org/0000-0002-2886-886X
Kaushik, Akash K.
Cai, Ling
Kasiri, Sahba
Marriam, Ummay
Nham, Kien
Girard, Luc
Wang, Hui
Sun, Xiankai
Kim, James
Minna, John D. http://orcid.org/0000-0002-7776-0767
Unsal-Kacmaz, Keziban
DeBerardinis, Ralph J. http://orcid.org/0000-0002-2705-7432
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1K22CA226676-01A1, 1R01CA196851, SPORE P50CA70907, SPORE P50CA070907, R35CA22044901)
American Lung Association (LCD-614827)
V Foundation for Cancer Research (V2019-022)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (5T32HL098040)
American Cancer Society (RSG-16-090-01-TBG)
Cancer Prevention and Research Institute of Texas (RP160652, RP160089)
Howard Hughes Medical Institute
Article History
Received: 15 April 2020
Accepted: 22 October 2020
First Online: 30 November 2020
Competing interests
: R.J.D. is an advisor for Agios Pharmaceuticals. J.D.M. receives cell line licensing royalties from the National Institutes of Health and UTSW. The other authors declare no competing interests.